| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VIEKIRA XR | 208624 | 001 | NDA | DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR | TABLET, EXTENDED RELEASE;ORAL | EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | 2016/07/22 | 2016/07/22 | ABBVIE | Discontinued |